Emmessar Biotech & Nutrition has informed that pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of Board of Directors of the Company, will be held on Friday, February 11, 2022, at 2.30 pm, to consider and approve the Unaudited Financial Results of the Company, for the Quarter and Nine Months ended December 31, 2021. Further, Trading Window for dealing in Securities of the Company shall remain closed from January 01, 2022 till expiry of 48 hours after declaration of Un-Audited Financial Results, as intimated vide letter dated 31st December, 2021.
The above information is a part of company’s filings submitted to BSE.
